CClinicalTrials.gg
CompletedNCT05936944iWOnDerUpdated Oct 2, 2025

Role of Natural Light in the Prevention of Delirium After Cardiac Surgery: a Prospective Observational Study With Historical Control

An observational study in Intensive Care Unit Delirium, Postoperative Delirium and Cardiac Surgery, sponsored by Azienda Ospedaliero-Universitaria di Parma. Completed at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-10-02.

Sponsored by Azienda Ospedaliero-Universitaria di Parma · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
448
Ages
18 Years and older
Sex
All
01

Study summary

Postoperative delirium is a common complication that usually occurs acutely within the first 24 hours after surgery and resolves within 72 hours; it is common in all medical areas and particularly affects patients over the age of 65 and those with pre-existing cognitive impairments. It is characterized by difficulty organizing and coordinating thoughts and by slowing down motor functions that are observed for a short period after surgery.

The study will be an observational prospective study with historical control (pre/post-study) whose primary objective is to identify the incidence of postoperative delirium in patients undergoing cardiac surgery. The population will be adult patients undergoing cardiac surgery at our University Hospital over a period of 12 months. The intervention will be exposure to totally artificial light (for patients hospitalized after the relocation of the department to its original location). The comparator will be exposure to natural light (for patients who will be hospitalized during our temporary transfer to an environment with natural lighting). The outcome will be the incidence of delirium, measured with the Confusion Assessment Method-Intensive Care Unit (CAM-ICU) scale; episodes of agitation requiring sedative drugs; time elapsed before onset of delirium. The study will last 12 months.

02

Conditions studied

  • Intensive Care Unit Delirium
  • Postoperative Delirium
  • Cardiac Surgery

Browse trials for

Keywords

  • cardiac surgery
  • postoperative delirium
  • natural light
03

In context

Emergence Delirium

763 studies on the registry are indexed under Emergence Delirium; 241 are open to participants now.

This study's enrollment of 448 is above the median of 164 across 280 observational studies indexed under Emergence Delirium.

Browse Emergence Delirium studies →

Lead sponsor

Azienda Ospedaliero-Universitaria di Parma is the lead sponsor of 43 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

All adult patients undergoing cardiac surgery with planned postoperative ICU admission. All tipes of cardiac surgery, irrespective of surgical access or technique, but excluding surgery performed under total circulatory arrest (totale suspension of brain perfusion). Patients will be excluded if they are unable to perform CAM-ICU assessment, if they were diagnosed with major depression or moderate/severe dementia and if they were already in ICU before surgery. Emergent surgery will also be an exclusion criteria.

Inclusion criteria

  • planned cardiac surgery
  • planned ICU admission after surgery

Exclusion criteria

Exclusion Criteria:

  • cardiac surgery with total suspension of cerebral perfusion
  • patient with diagnosed dementia or major depressive disorder
  • patient unable to perform CAM-ICU evaluation
  • emergent surgery
  • patient in ICU before surgery
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
448 participants (actual)
Patient registry
No

Groups and cohorts

  • Natural Light

    Group of patients enrolled in the first ICU, with natural lighting

  • Artificial Light

    Group of patients enrolled in the second ICU, with totally artificial lighting

    Other: Exposure to totally artificial lighting

Interventions

  • OtherExposure to totally artificial lighting

    The second group of patients will be admitted to an ICU without windows and with a totally artificial lighting

06

What researchers measure

Primary outcomes

  1. Postoperative delirium

    Occurrence of delirium, diagnosed with at least one positive CAM-ICU evaluation

    Time frame: first five postoperative days or ICU discharge (wichever comes first)

Secondary outcomes

  1. Postoperative episodes of agitation

    number of episodes of postoperative agitation (RASS\>+1) requiring farmacological treatment

    Time frame: first five postoperative days or ICU discharge (wichever comes first)

07

Study locations

1 site
  • Ospedale Maggiore di Parma
    Parma, PR 43126, Italy
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 2, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05936944
Lead sponsor
Azienda Ospedaliero-Universitaria di Parma
Responsible party
Davide Nicolotti (Principal Investigator, Azienda Ospedaliero-Universitaria di Parma) — Principal investigator
First posted
Jul 10, 2023
Start date
Jun 14, 2023
Primary completion
Jun 22, 2024
Completion
Jun 22, 2024
Last update
Oct 2, 2025

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion